The history of GLP-1 agonist drugs began in the 1960s80s
Retatrutide is a medication currently being tested for type 2 diabetes and weight management
GLP-1RAs can suppress local inflammation caused by agonistic anti-CD3 antibody through intraepithelial lymphocytes (IELs) (Wong et al., 2022)
"Smaller players will likely need to demonstrate either superior tolerability, novel indication-specific efficacy, meaningfully different dosing convenience, or combination strategies that address limitations of current agents, particularly muscle loss, rather than simply competing on weight-loss magnitude alone," says Nadolsky
Hier volgt een gedetailleerde analyse van de belangrijkste voordelen: Weefselherstel BPC-157 bevordert de genezing van pezen, ligamenten, spieren en zelfs botten